enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Zuranolone - Wikipedia

   en.wikipedia.org/wiki/Zuranolone

   Zuranolone, sold under the brand name Zurzuvae, is a medication used for the treatment of postpartum depression. [5] [6] It is taken by mouth.[5]The most common side effects include drowsiness, dizziness, diarrhea, fatigue, nasopharyngitis, and urinary tract infection.

3. Allopregnanolone - Wikipedia

   en.wikipedia.org/wiki/Allopregnanolone

   Allopregnanolone is a naturally occurring neurosteroid which is made in the body from the hormone progesterone. [10] [11] As a medication, allopregnanolone is referred to as brexanolone, sold under the brand name Zulresso, [6] [12] and used to treat postpartum depression.

4. Obstetric medicine - Wikipedia

   en.wikipedia.org/wiki/Obstetric_medicine

   The use of medicine to treat postpartum depression is a subject for debate, since some research indicates that the use of antidepressants during pregnancy can lead to physical malformations and long-term health problems of the baby [10] Other forms of treatment include support groups and psychotherapy.

5. The Future Of Postpartum Depression Treatment Is Brighter ...

   www.aol.com/future-postpartum-depression...

   The goal is for science to reach a place where tailored treatment for individuals with postpartum depression is possible, much like it has for cancer, says Dr. Meltzer-Brody. One-size-fits-all ...

6. FDA approves oral medication treating postpartum depression - AOL

   www.aol.com/lifestyle/fda-approves-oral...

   Sep. 7—A new drug treating postpartum depression was approved earlier this month by the Food and Drug Administration — possibly filling a gap in care, depending on the drug's accessibility to ...

7. Diabetes medication - Wikipedia

   en.wikipedia.org/wiki/Diabetes_medication

   A Cochrane systematic review from 2011 showed that treatment with Sulfonylureas did not improve control of glucose levels more than insulin at 3 nor 12 months of treatment. [28] This same review actually found evidence that treatment with Sulfonylureas could lead to earlier insulin dependence, with 30% of cases requiring insulin at 2 years. [28]